SARS‐CoV‐2 vaccine‐related adverse events in Zimbabwe: The need to strengthen pharmacovigilance in resource‐limited settings

Murewanhema, Grant; Dzinamarira, Tafadzwa; Madziva, Roda; Herrera, Helena; Musuka, Godfrey

doi:10.1002/pds.5393

SARS‐CoV‐2 vaccine‐related adverse events in Zimbabwe: The need to strengthen pharmacovigilance in resource‐limited settings

Murewanhema, Grant; Dzinamarira, Tafadzwa; Madziva, Roda; Herrera, Helena; Musuka, Godfrey

Authors

Grant Murewanhema

Tafadzwa Dzinamarira

RODA MADZIVA Roda.Madziva@nottingham.ac.uk
Associate Professor

Helena Herrera

Godfrey Musuka

Citation

Murewanhema, G., Dzinamarira, T., Madziva, R., Herrera, H., & Musuka, G. (2022). SARS‐CoV‐2 vaccine‐related adverse events in Zimbabwe: The need to strengthen pharmacovigilance in resource‐limited settings. Pharmacoepidemiology and Drug Safety, 31(3), 379-380. https://doi.org/10.1002/pds.5393

Journal Article Type	Letter
Acceptance Date	Dec 6, 2021
Online Publication Date	Dec 26, 2021
Publication Date	2022-03
Deposit Date	Jan 4, 2022
Publicly Available Date	Dec 27, 2022
Journal	Pharmacoepidemiology and Drug Safety
Print ISSN	1053-8569
Electronic ISSN	1099-1557
Publisher	Wiley
Peer Reviewed	Peer Reviewed
Volume	31
Issue	3
Pages	379-380
DOI	https://doi.org/10.1002/pds.5393
Keywords	Pharmacology (medical); Epidemiology
Public URL	https://nottingham-repository.worktribe.com/output/7164338
Publisher URL	https://onlinelibrary.wiley.com/doi/10.1002/pds.5393